Peptide therapy TikTok claims: what the science actually supports

What did @paulbakhtiar actually say?

@paulbakhtiar made two distinct claims: that Delta Sleep Inducing Peptide (DSIP) was "developed for people traveling overseas" dealing with jet lag, and that taking it "two to three times a week" can reset a disrupted circadian rhythm until sleep normalizes. He frames it as a practical protocol for people who simply can't sleep well and don't know what to do about it. The pitch is confident and prescriptive, which is exactly why it deserves scrutiny.

The jet lag origin story is meant to establish credibility, the implication being that DSIP was clinically validated for a specific real-world problem. The twice-to-three-times-weekly dosing advice is presented as established protocol. Neither claim holds up cleanly under examination.

Does the science back this up?

The honest answer is: barely, and not in the way he implies. DSIP has been studied, but the research is old, small, and inconsistent. It was not "developed" for jet lag travelers in any meaningful clinical sense.

DSIP was first isolated from rabbit cerebrospinal fluid in 1974 by Monnier et al. and published in the journal Experientia. Early animal studies showed it could modulate slow-wave sleep. Human research that followed was limited and produced mixed results. A frequently cited 1984 study by Schneider-Helmert in Neuropsychobiology found some improvements in sleep latency in small patient groups, but the sample sizes were too small and controls too weak to draw firm conclusions.

On the circadian rhythm front, there is some evidence that DSIP interacts with the hypothalamic-pituitary axis and may influence hormonal rhythms, but characterizing it as a circadian rhythm "reset" mechanism is a stretch. The jet lag application has no large-scale randomized trial behind it. There is no approved indication. The mechanistic story is biologically plausible in parts, but plausible is not proven.

What did they get wrong (or right)?

He got the general category right: DSIP is genuinely associated with sleep research, and interest in it for sleep quality is not baseless. That much is fair.

What he got wrong is almost everything surrounding the framing. Describing DSIP as something "developed for" jet lag travelers implies a deliberate clinical development pathway that does not exist. DSIP was discovered in a lab context and studied experimentally. It was never developed as a jet lag therapeutic, never approved for that use, and there is no Phase III trial backing the jet lag claim.

The "two to three times a week" dosing advice is the part that should raise the most flags. This kind of specific dosing language, presented casually in a TikTok, blurs the line between educational content and medical advice. DSIP has no established human dosing protocol validated in peer-reviewed literature. The dosing he describes may be circulating in peptide-enthusiast communities, but community consensus is not clinical evidence.

He also does not mention that DSIP is not FDA-approved, is not a regulated drug in the United States, and exists in a research-chemical gray zone for human use. That omission matters when the audience is people with real sleep problems looking for real solutions.

What should you actually know?

DSIP is real, it has been studied, and there is enough biological rationale that serious researchers have looked at it. But the gap between "studied in small trials since the 1970s" and "take this to fix your circadian rhythm" is significant.

Sleep disorders are genuinely difficult to treat. Conditions like chronic insomnia, delayed sleep phase disorder, and shift-work disorder cause real harm and are underserved by conventional medicine. It is understandable that people look outside standard options. But peptides marketed for sleep are operating almost entirely on mechanistic plausibility and anecdote right now.

If you are dealing with seriously disrupted sleep, the interventions with the strongest evidence base remain cognitive behavioral therapy for insomnia (CBT-I), light therapy for circadian disorders, and in some cases physician-supervised pharmacotherapy. Any peptide protocol for sleep should be discussed with a licensed clinician who can evaluate your full picture, not sourced from a TikTok dosing suggestion.

DSIP also has not been adequately studied for long-term safety in humans. Citing its 50-year research history sounds reassuring, but most of that research was preclinical or involved very short study durations in small human cohorts. Unknown does not mean dangerous, but it does mean you are accepting risk without a full accounting of what that risk is.